Qube Research & Technologies Ltd - RUBIUS THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 42 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$17,000
-48.5%
38,225
-2.2%
0.00%–
Q2 2022$33,000
-89.8%
39,071
-33.1%
0.00%
-100.0%
Q1 2022$322,000
+5.2%
58,414
+84.9%
0.00%
+50.0%
Q4 2021$306,000–31,587–0.00%–
 Download
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders